CCCS-SSAI WikiRecs Clinical Practice Guideline: vasopressors in early traumatic shock

Canadian Journal of Anesthesia

Volumn 64, Issue 7, 2017, Pages 766-768

  Rochwerg, Bram ^a   Hylands, Mathieu ^b   Møller, Morten ^c   Asfar, Pierre ^d   Cohen, Dian ^e   Khadaroo, Rachel G ^f   Laake, John H ^g   Perner, Anders ^c   Tanguay, Teddie ^h   Widder, Sandy ^f   Vandvik, Per ^i,j,k   Kristiansen, Annette ^i,k   Lamontagne, François ^b,l  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c Rigshospitalet   (Denmark)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e Massawippi Valley Health Centre   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h Canadian Critical Care Society   (Canada)

ⁱ UNIVERSITY OF OSLO   (Norway)

^j NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^k INNLANDET HOSPITAL TRUST   (Norway)

^l CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE AGENT; VASOCONSTRICTOR AGENT;

ARTICLE; CLINICAL PRACTICE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN RELATION; MEDICAL SOCIETY; MORTALITY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PUBLIC-PRIVATE PARTNERSHIP; RISK FACTOR; SYSTEMATIC REVIEW; TRAUMATIC SHOCK; TRUSTWORTHY; ADULT; TIME FACTOR;

ADULT; HUMANS; SHOCK, TRAUMATIC; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 85018697881     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-017-0879-z     Document Type: Article

References (7)

1. Batistaki C, Kostopanagiotou G, Myrianthefs P, et al. Effect of exogenous catecholamines on tumor necrosis factor alpha, interleukin-6, interleukin-10 and beta-endorphin levels following severe trauma. Vascular Pharmacol 2008; 48: 85-91.
2. Sperry JL, Minei JP, Frankel HL, et al. Early use of vasopressors after injury: caution before constriction. J Trauma 2008; 64: 9-14.
3. Van Haren RM, Thorson CM, Valle EJ, et al. Vasopressor use during emergency trauma surgery. Am Surg 2014; 80: 472-8.
4. Plurad DS, Talving P, Lam L, Inaba K, Green D, Demetriades D. Early vasopressor use in critical injury is associated with mortality independent from volume status. J Trauma 2011; 71: 565-70; discussion 570-2.
5. Cohn SM, McCarthy J, Stewart RM, Jonas RB, Dent DL, Michalek JE. Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg 2011; 35: 430-9.
6. Hemkens LG, Contopoulos-Ioannidis DG, Ioannidis JP. Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey. BMJ 2016; 352: i493.
7. Beloncle F, Meziani F, Lerolle N, Radermacher P, Asfar P. Does vasopressor therapy have an indication in hemorrhagic shock? Ann Intensive Care 2013; 3: 13.